Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Vir Biotechnology, Inc. VIR

Set alert

Price alert · VIR

All alert types
11.00 USD 0.00 0.00%

At close

11.16 +0.16 +1.45%

Pre-market · Nov 3, 8:58 AM ET

Bid
11.00 × 1
Ask
11.01 × 1
11.00 Day range 11.55
4.82 52-week range 12.19
YTD
+82.42%
1 year
+96.43%
Open
11.36
Prev close
11.00
Mkt cap
1.86B
Vol
1.38M
Avg vol
1.93M
EPS
-1.76
P/E
0.00
Div yield
0.00%
More statistics
Low
11.00
High
11.55
Forward P/E
-4.46
Beta
1.74
Short ratio
7.15
Inst. own
84.46%
Dividend
0.00
Ex-div date
Earnings
Nov 4, 2026
50-d avg
10.94
200-d avg
9.52
1y target
21.00

1D chart

Chart tools
Interval
1m5m15m30m

Signals (42)
NameTimeAgo
RSI: Oversold3:58 PM17 hours ago
MACD: Sell Signal3:51 PM17 hours ago
SMA: Bearish3:50 PM17 hours ago
SMA: Bullish3:49 PM17 hours ago
SMA: Bearish3:47 PM17 hours ago
MACD: Buy Signal3:43 PM17 hours ago
RSI: Oversold3:35 PM17 hours ago
MACD: Sell Signal3:17 PM18 hours ago
RSI: Overbought3:03 PM18 hours ago
SMA: Bullish2:53 PM18 hours ago
SMA: Bullish2:51 PM18 hours ago
MACD: Buy Signal2:42 PM18 hours ago
MACD: Sell Signal2:20 PM19 hours ago
MACD: Buy Signal1:55 PM19 hours ago
MACD: Sell Signal1:52 PM19 hours ago
MACD: Buy Signal1:51 PM19 hours ago
RSI: Oversold1:44 PM19 hours ago
MACD: Sell Signal1:16 PM20 hours ago
MACD: Buy Signal12:58 PM20 hours ago
MACD: Sell Signal12:55 PM20 hours ago

Newest 20 of 42.

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 21.00 +90.9% upside
Target (low)
15.00
Target (mean)
21.00
Target (high)
30.00
Ratings (0m) 9 9 buy · 0 hold · 0 sell
  • Strong buy3
  • Buy6
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 9
  • 1 month ago 10
  • 2 months ago 10

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

VIR analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.74517-0.95 – -0.58-1.17+36.3%1.38M+475.0%6
Next quarter-0.62283-0.78 – -0.487-0.31-100.9%6.20M-90.3%6
Current year-1.77-2.22 – -1.37-3.16+44.0%239.48M+249.3%6
Next year-2.47-2.94 – -1.57-1.77-39.3%76.27M-68.2%6

Upgrades and downgrades

The latest rating changes

VIR analyst upgrades and downgrades
DateFirmActionFromTo
Oct 7, 2026HC Wainwright & Co.MaintainedBuyBuy
Jun 11, 2026Morgan StanleyMaintainedOverweightOverweight
Jun 3, 2026Leerink PartnersMaintainedOutperformOutperform
Mar 4, 2026HC Wainwright & Co.MaintainedBuyBuy
Feb 25, 2026BarclaysMaintainedOverweightOverweight
Feb 24, 2026Morgan StanleyMaintainedOverweightOverweight
Feb 24, 2026Evercore ISI GroupMaintainedOutperformOutperform
Feb 24, 2026NeedhamMaintainedBuyBuy
Feb 9, 2026NeedhamReiteratedBuyBuy
Dec 30, 2025HC Wainwright & Co.ReiteratedBuyBuy
Sep 15, 2025HC Wainwright & Co.ReiteratedBuyBuy
Sep 3, 2025Evercore ISI GroupInitiated—Outperform
Aug 27, 2025B of A SecuritiesUpgradeNeutralBuy
Jul 11, 2025Raymond JamesInitiated—Outperform
May 22, 2025NeedhamReiteratedBuyBuy
May 12, 2025NeedhamMaintainedBuyBuy
Apr 17, 2025Goldman SachsMaintainedBuyBuy
Feb 28, 2025BarclaysMaintainedOverweightOverweight
Feb 28, 2025HC Wainwright & Co.ReiteratedBuyBuy
Feb 27, 2025NeedhamReiteratedBuyBuy
Jan 31, 2025HC Wainwright & Co.ReiteratedBuyBuy
Jan 13, 2025Leerink PartnersMaintainedOutperformOutperform
Jan 10, 2025HC Wainwright & Co.ReiteratedBuyBuy
Jan 9, 2025Morgan StanleyUpgradeEqual-WeightOverweight
Jan 9, 2025JP MorganMaintainedNeutralNeutral
Nov 20, 2024HC Wainwright & Co.ReiteratedBuyBuy
Nov 20, 2024NeedhamReiteratedBuyBuy
Nov 4, 2024BarclaysMaintainedOverweightOverweight
Nov 4, 2024HC Wainwright & Co.ReiteratedBuyBuy
Nov 1, 2024NeedhamReiteratedBuyBuy